Annual Revenue ($)

Edwards Lifesciences revenue was $4.39 b in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$3.44 b$3.72 b$4.35 b$4.39 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q3, 2020Q1, 2021
Revenue$894.8 m$943.7 m$906.6 m$993 m$1.09 b$1.09 b$1.13 b$1.14 b$1.22 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Edwards Lifesciences revenue breakdown by business segment: 17.0% from Critical Care, 19.4% from Surgical Structural Heart, 63.0% from Transcatheter Aortic Valve Replacement and 0.6% from Other

Edwards Lifesciences revenue breakdown by geographic segment: 21.6% from Europe, 9.9% from Rest of World, 10.2% from Japan and 58.2% from United States

FY, 2019FY, 2017FY, 2018
Surgical Heart Valve Therapy$807.1 m$761.6 m
Transcatheter Heart Valve Therapy$2.03 b$2.29 b
Critical Care$740.2 m$601 m$674.5 m
Surgical Structural Heart$841.7 m
Transcatheter Mitral and Tricuspid Therapies$28.2 m
Transcatheter Aortic Valve Replacement$2.74 b
FY, 2019FY, 2017FY, 2018
Europe$941.2 m$831 m$885.1 m
Rest of World$429.4 m$346.4 m$385.6 m
Japan$444.7 m$350.3 m$396.8 m
United States$2.53 b$1.91 b$2.06 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu